Please login to the form below

Not currently logged in
Email:
Password:

Immunocore

This page shows the latest Immunocore news and features for those working in and with pharma, biotech and healthcare.

GSK gets serious about immunotherapy with Merck deal worth up to $4.2bn

GSK gets serious about immunotherapy with Merck deal worth up to $4.2bn

It also adds to its existing IO alliance with UK biotech Immunocore in novel T-cell immunotherapy.

Latest news

More from news
Approximately 8 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    Until earlier this year she was the Chief Business Officer at Immunocore (since 2013), one of the most hotly-tipped UK biotech companies in the field of immunotherapy. ... At Immunocore, Eva-Lotta contributed significantly to a $320m Series A fundraising

  • Pharma deals in July 2015 Pharma deals in July 2015

    This month, Immunocore which develops T-cell receptor based drugs and has a lead product in Phase IIa, raised $320m (£205m) via a private financing round from a syndicate of investors, ... It is hoped that Immunocore and Mereo are signs that at long

  • Pharma deals in March 2015 Pharma deals in March 2015

    Sir John Bell, Regius Professor of Medicine at Oxford University and a non-executive director of Immunocore has criticised the City of London for failing to provide financial support to life

  • Deal Watch table for July 2014 Deal Watch table for July 2014

    30. Immunocore/ Eli Lilly. Co-discovery /co-development, options (cost/profit share). ImmTAC (Immune mobilising mTCR Against Cancer) technology (discovery)    . 25+. Noven Therapeutics/ ANI Pharmaceuticals. Acquisition of NDA †. Lithobid

  • Interview: AstraZeneca's Susan Galbraith Interview: AstraZeneca's Susan Galbraith

    Other deals include an alliance with the UK biotech Immunocore via AZ's MedImmune subsidiary and an expansion of an existing personalised drug partnership with Horizon Discovery.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    David Berman joins Immunocore. Immunocore has bolstered its R&D efforts after it named David Berman (pictured below) as its head of R&D. ... I am excited and honoured to be charged with driving Immunocore’s research and development efforts forward.”.

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Latest movers in pharma and biotech. Immunocore names new CEO. Bahija Jallal, Immunocore's next CEO. ... Immunotherapy-focused UK biotech company Immunocore has unveiled Bahija Jallal as its new chief executive and director of the board.

  • Industry appointments Industry appointments

    Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma

  • Immunocore appoints chief financial officer Immunocore appoints chief financial officer

    Paul Fry brings leadership experience from GlaxoSmithKline. Oxford, UK-based Immunocore has appointed Paul Fry as its chief financial officer. ... As Immunocore continues to grow we are continually looking for outstanding individuals such as Paul to

  • Immunocore names CEO Immunocore names CEO

    Eliot Forster is chairman of the MedCity project. The UK-based biotech Immunocore has appointed industry veteran Dr Eliot Forster as CEO. ... His significant drug development experience will be invaluable to Immunocore as we continue to deliver within

More from appointments
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics